HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Vitamin C in complementary oncology--update 2009].

Abstract
The antioxidant perhaps most widely used in complementary oncology is vitamin C, particularly by intravenous injection. In light of the recent clinical pharmacokinetic findings, the in vitro evidence of anti-tumour mechanisms and some well-documented cases of advanced cancers the role of high-dose intravenous vitamin C therapy in cancer treatment should be reassessed. High dose intravenous vitamin C therapy may have benefits in patients with advanced cancers, and cancers with poor prognosis and limited therapeutic options, but further clinical studies regarding the safety and efficacy of this therapy are necessary, especially in Germany.
AuthorsUwe Gröber
JournalMedizinische Monatsschrift fur Pharmazeuten (Med Monatsschr Pharm) Vol. 32 Issue 7 Pg. 263-7 (Jul 2009) ISSN: 0342-9601 [Print] Germany
Vernacular TitleVitamin C in der komplementären Onkologie. Update 2009.
PMID19731754 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Antioxidants
  • Ascorbic Acid
Topics
  • Antioxidants (administration & dosage, therapeutic use)
  • Ascorbic Acid (administration & dosage, therapeutic use)
  • Humans
  • Infusions, Intravenous
  • Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: